Intellia Therapeutics to present at three major healthcare investor conferences in May and June 2026.

Intellia Therapeutics, a biopharmaceutical company specializing in CRISPR gene editing, announced its participation in three upcoming investor conferences: Bank of America Securities Health Care Conference on May 12, RBC Capital Markets Global Healthcare Conference on May 20, and Jefferies Global Healthcare Conference on June 3, 2026. The company's management will engage in fireside chats at these events, which will be webcast live and available for replay. This participation highlights Intellia's ongoing efforts to engage with investors and showcase its advancements in gene editing technology and clinical development.